UCLA

Risk benefit of the vaccines is NEGATIVE according to a new paper from Stanford, UCLA, others. Whoops!

by Steve Kirsch, Steve Kirsch’s Newsletter: Peter Doshi is an author of this paper. This paper puts my status as a “misinformation spreader” in serious jeopardy. They may have to start calling me a “truth teller” soon. This preprint paper, Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials, was written by a team […]

Porkins Policy Radio episode 142 Aaron Franz on sea slug memories

Aaron Franz of TheAgeofTransistions.com joins us for the first hour. We begin by talking about Aaron’s new live version of Trans Resister Radio and Uncle the podcast. Aaron and I then discuss the topic of the imagined dividing line between the real and the fantastic, the objective and the subjective. We talk about how reality and fantasy have begun to blur increasingly over the past several years. Using Elon Musk as an example we discuss how Musk’s increasingly bizarre pronouncements illustrate this concept.

Why Is UCLA Doing Pfizer’s Dirty Work in India?

On the morning of March 14, a first-year UCLA medical student named Kayla Gu approached the microphone at a meeting of her university’s Board of Regents. Speaking in a white coat with a stethoscope around her neck, she urged the university to drop a patent claim pending at India’s high court, which the David Geffen School of Medicine filed in order to block generic production of the prostate cancer drug enzalutamide, trade name Xtandi. Though developed at UCLA with tens of millions in funding from the National Institutes of Health and the U.S.